Embarking on your journey to cyber resilience: Actionable steps for the pharmaceuticals and life sciences sector.
Join our webinar for security and technology leaders across the pharmaceuticals and life sciences sector on 23 July 2020, 15:00-16:00 BST where we will discuss how to take your organisation from cyber secure to cyber resilient.
David Prince, Director of Cyber, Baringa
John Wise, Programme Coordinator at PRISME and consultant for the Pistoia Alliance
In recent years, cyber security conversations across the pharmaceuticals and life sciences sector have moved from ‘are we secure’ to ‘are we resilient’? The driver of this change is the considerable increase in the volume, complexity and criticality of information that is exchanged across value chains and between different organisations, increasing exposure to a multitude of cyber security risks. As companies continue to leverage, process and collaborate over ever larger data sets, the harm that could be caused by cyber loss events is significant. It is critical for pharmaceutical and life sciences organisations to understand not just how to prevent incidents, but to ensure correct structures and processes are in place to respond to incidents.
Changes to privacy legislation have started this journey. Regulatory scrutiny is expected to become more cyber resilience-focused, going beyond infrastructure to include dependent processes, systems, people, and suppliers.
To further explore how cyber resilience is understood, approached and addressed across the pharmaceutical and life sciences sector, Baringa will be hosting a webinar to discuss:
- Common challenges
- Common steps to becoming cyber resilient
- A possible future industry roadmap to improve security and resilience
To register on the webinar just fill in the form below.
If you can’t make the webinar, you can reach out directly to David Prince, Baringa, to arrange a personal call.